Table 4.
Results of Phase 1 comparisons, including 1) ANCOVA between group comparisons (correcting for age, sex, and current medication use) and 2) post-hoc comparisons between estimated marginal means (corrected for covariates) and age-based normative data
ANCOVA ā between group comparisons |
Adjusted marginal means from ANCOVA - Post-hoc comparisons with normative data |
||||||
---|---|---|---|---|---|---|---|
| |||||||
Cognitive domains | F | p-value | Eta2 | ADHD | Mood disorder | ASD | Psychosis |
General Ability Index | 1.61 | .19 | .013 | 102.9 (12.4)* | 107.8 (15.5)* | 103.9 (17.5) | 101.7 (13.8) |
(101.2;104.6) | (103.4;112.2) | (99.3;108.4) | (96.7;106.8) | ||||
253 | 41 | 34 | 29 | ||||
Response Variability** | .38 | .77 | .004 | 53.8 (10.8)* | 53.2 (11.6) | 51.9 (12.6) | 55.1 (11.2) |
(52.3;55.3) | (49.3;57.2) | (47.8;56.0) | (49.9;60.1) | ||||
220 | 35 | 29 | 19 | ||||
Working Memory | 1.84 | .14 | .015 | 94.8 (12.0)* | 97.4 (11.4) | 94.9 (16.3) | 90.1 (16.2)* |
(93.2;96.4) | (93.2;101.5) | (90.5;99.3) | (85.3;94.9) | ||||
253 | 41 | 34 | 29 | ||||
Inhibition** | 1.07 | .36 | .010 | 52.1 (10.5)* | 53.6 (10.4) | 54.4 (9.1) | 55.7 (10.3) |
(50.8;53.5) | (50.0;57.2) | (50.7;58.1) | (51.0;60.4) | ||||
220 | 35 | 29 | 19 | ||||
Shifting | .77 | .51 | .008 | 8.2 (3.5)* | 9.2 (3.5) | 8.6 (4.2) | 8.5 (3.1) |
(7.7;8.7) | (8.0;10.4) | (7.2;10.1) | (7.1;9.8) | ||||
219 | 38 | 24 | 28 |
Note. Values in table represent adjusted marginal means (SD), (95% CI), and sample size from ANCOVA;
pā¤0.0125 (significant after Bonferroni correction);
Low scores indicate worse performance, with the exception of measures designated with **, in which high scores reflect greater difficulty.